New Board Directors elected by ARCS Australia

At yesterday’s Annual General Meeting of ARCS Australia Limited, the President and Chair of the Board George Papadopoulos announced the results of the recent board elections. Three vacancies were put to a vote to ARCS members for an appointment of three years.

ARCS membership is made up of individuals working in regulatory affairs, clinical research, health economics, medical information and other disciplines who work in the development and quality use of therapeutic goods.

Current Board Director Robert Kent, Research Operations Manager at The Kinghorn Cancer Centre, has been re-elected for another term. He was first appointed in July 2017 and in particular has been representing the interests of research sites while working with the Board to reshape and revitalise ARCS.

Newly elected was former ARCS Board Director and CEO Marisa Petersen, who is a Life Member of ARCS and recently retired from leadership roles in the therapeutic goods industry. Marisa’s last role was CEO of George Clinical and she is well known to ARCS members and in the sector.

Also newly elected was Andrew Carter, Founder and current Managing Director of Commercial Eyes, based in Melbourne. Andrew brings nearly 30 years’ experience in the medicines and medical device industry.

“I welcome the new and returning Board Directors and look forward to working with each one to shape the future of the organisation,” said George Papadopoulos.

“I’d like to thank retiring Board Director and Vice-President, Kaylene O’Shea, who was first appointed in November 2014 and has contributed substantially to the strategic direction of ARCS in that time; as well as thanking Jessica Keast, who has been a Board Director since November 2016 and has equally contributed to ARCS strategic direction. Lastly, I would like to thank Naomi Beveridge, who stepped down as Independent Director prior to the AGM. It has been a privilege and a pleasure working with Kaylene, Jessica and Naomi over the past years and I would like to thank them again for their contributions to ARCS and the healthcare sector,” concluded George Papadopoulos.

You may also like APPA announces 2020 executive committee

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.